Genomma Lab Internacional Sab De Cv operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genomma Lab Internacional Sab De Cv with three other
pharmaceutical manufacturers in Latin America:
sales of 1.89 billion Brazilian Reals [US$588.31 million]
of which 84%
was Diagnostic Medicine),
Ouro Fino Saude Animal Participacoes SA
(534.05 million Brazilian Reals [US$165.80 million]
of which 82%
was Production Animals), and
Diagnosticos Da America SA
based in Brazil
(2.79 billion Brazilian Reals [US$867.55 million]
of which 100%
was servi os auxiliares).
During the year ended December of 2015, sales at
Genomma Lab Internacional Sab De Cv were 11.04 billion Mexican Pesos (US$514.25 million).
decrease of 4.3%
versus 2014, when the company's sales were 11.54 billion Mexican Pesos.
Contributing to the drop in overall sales was the 46.6% decline
in Otc, from 3.88 billion Mexican Pesos to 2.07 billion Mexican Pesos.
However, these declines were partially offset by the increase in sales of
Services (up 224.5% to 27.52 million Mexican Pesos)
Other (up 30.8% to 7.10 billion Mexican Pesos)